Healthify, a company that works with managed care organizations to integrate social determinants of health (SDoH) into the healthcare ecosystem, has announced that Twentyeight Health, a femtech startup that provides affordable and convenient reproductive and sexual care, is joining its network of community-based organizations working to address social needs and improve outcomes for disadvantaged populations.

“We are very excited to be partnering with Healthify as it expands our ability to increase access to reproductive and sexual health across the country,” said Bruno Van Tuykom, Co-Founder of Twentyeight Health.

Twentyeight Health provides birth control pills, patch, ring, shot and emergency contraception (Plan B or equivalent) prescriptions and delivery, available for a low-cost or covered by insurance including Medicaid. Now, health plans and providers will be able to refer individuals to Twentyeight Health from within the Healthify platform. Through this new partnership, these organizations will work together to break down barriers that underserved women may face when looking to access reproductive and sexual health services, such as high prescription costs and contraceptive deserts.

“This partnership comes at a time when many women in vulnerable communities are in need of prescription delivery or virtual healthcare services due to COVID-19,” said Amy Fan, Co-Founder of Twentyeight Health. “By working with Healthify, we can strengthen our efforts to ensure that all women who want birth control are able to access it.”

After launching in 2018, Twentyeight Health is now active in six states including Florida, Maryland, New Jersey, New York, North Carolina, and Pennsylvania. Over the next six months, the company plans to expand its efforts to several other states as well.

said Manik Bhat, Founder and Chief Executive Officer of Healthify. “Together, we can expand Twentyeight Health’s impact by offering their services to help individuals receive the low- or no- cost birth control that is right for them.”

Show CommentsClose Comments

Leave a comment